Alpha 2.0
Login Register
» Articles » PMID: 38423693

Balancing the Risks and Benefits of CAR T-cell Therapy

Overview
Journal Lancet Haematol
Specialties Hematology
Oncology
Date 2024 Feb 29
PMID 38423693
Authors
The Lancet Haematology
Affiliations
Soon will be listed here.
Citing Articles

A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach.

Jung J, Kim J, Bae J, Woo S, Lee H, Shin J Sci Rep. 2024; 14(1):13641.

PMID: 38871843 PMC: 11176352. DOI: 10.1038/s41598-024-64466-x.

Charting new paradigms for CAR-T cell therapy beyond current Achilles heels.

Li Y, Hu Z, Li Y, Wu X Front Immunol. 2024; 15:1409021.

PMID: 38751430 PMC: 11094207. DOI: 10.3389/fimmu.2024.1409021.

Chordoma Genetic Aberrations and Targeted Therapies Panorama: A Systematic Literature Review.

Agosti E, Antonietti S, Zeppieri M, Ius T, Fiorindi A, Tel A J Clin Med. 2024; 13(9).

PMID: 38731241 PMC: 11084907. DOI: 10.3390/jcm13092711.